Estimation of feasible solution space using Cluster Newton Method: application to pharmacokinetic analysis of irinotecan with physiologically-based pharmacokinetic models
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-0509
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Estimation of feasible solution space using Cluster Newton Method: application to pharmacokinetic analysis of irinotecan with physiologically-based pharmacokinetic models ; volume:7 ; number:3 ; day:16 ; month:10 ; year:2013 ; pages:1-11 ; date:10.2013
BMC systems biology ; 7, Heft 3 (16.10.2013), 1-11, 10.2013
- Creator
-
Yoshida, Kenta
- Contributor
-
Maeda, Kazuya
Kusuhara, Hiroyuki
Konagaya, Akihiko
SpringerLink (Online service)
- DOI
-
10.1186/1752-0509-7-S3-S3
- URN
-
urn:nbn:de:1111-201607303437
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yoshida, Kenta
- Maeda, Kazuya
- Kusuhara, Hiroyuki
- Konagaya, Akihiko
- SpringerLink (Online service)
Other Objects (12)
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Constraint-based perturbation analysis with cluster Newton method: a case study of personalized parameter estimations with irinotecan whole-body physiologically based pharmacokinetic model
Adapting physiologically-based pharmacokinetic models for machine learning applications
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Constraint-based perturbation analysis with cluster Newton method: a case study of personalized parameter estimations with irinotecan whole-body physiologically based pharmacokinetic model
Adapting physiologically-based pharmacokinetic models for machine learning applications
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Constraint-based perturbation analysis with cluster Newton method: a case study of personalized parameter estimations with irinotecan whole-body physiologically based pharmacokinetic model
Adapting physiologically-based pharmacokinetic models for machine learning applications
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes